(c) 2024 PillSync.com

Morphine Sulfate 30 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Morphine sulfate extended-release tablets are an opioid agonist product indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. ( 1 ) Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations, reserve morphine sulfate extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. ( 1 ) Morphine sulfate extended-release tablets are not indicated as an as-needed (prn) analgesic. ( 1 ) Morphine sulfate extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [ see Warnings and Precautions (5.1) ] , reserve morphine sulfate extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Morphine sulfate extended-release tablets are not indicated as an as-needed (prn) analgesic.

zydus pharmaceuticals (usa) inc.


4 years ago OVAL PINK N 30 Morphine Sulfate 30 MG Extended Release Oral Tablet

OVAL PINK N 30

4 years ago OVAL PINK N 30 Morphine Sulfate 30 MG Extended Release Oral Tablet

N 30 OVAL PINK

16 HOW SUPPLIED/STORAGE AND HANDLING Morphine Sulfate Extended-Release Tablets 15 mg are oval, film-coated, green tablets debossed "N" on one side and "15" on the other. They are supplied as follows: NDC 68382-903-01…………Bottles of 100 tablets Morphine Sulfate Extended-Release Tablets 30 mg are oval, film-coated, pink tablets, debossed "N" on one side and "30" on the other. They are supplied as follows: NDC 68382-904-01…………Bottles of 100 tablets Morphine Sulfate Extended-Release Tablets 60 mg are oval, film-coated, white tablets debossed "N" on one side and "60" on the other. They are supplied as follows: NDC 68382-905-01…………Bottles of 100 tablets Morphine Sulfate Extended-Release Tablets 100 mg are oval, film-coated, gray tablets debossed "N" on one side and "100" on the other. They are supplied as follows: NDC 68382-906-01…………Bottles of 100 tablets Morphine Sulfate Extended-Release Tablets 200 mg are oval, film-coated, brown tablets debossed "N" on one side and "200" on the other. They are supplied as follows: NDC 68382-907-01…………Bottles of 100 tablets Store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F) [see USP Controlled Room Temperature.] Dispense in a tight, light-resistant and child-resistant container. CAUTION DEA FORM REQUIRED


More pills like OVAL N 30

Related Pills

Morphine Sulfate MORPHINE SULFATE 15 mg

Zydus Pharmaceuticals (USA) Inc.

24 HR Isosorbide Mononitrate 30 MG Extended Release Oral Tablet

ncs healthcare of ky, inc dba vangard labs

Lyrica 300 MG Oral Capsule

Parke-Davis Div of Pfizer Inc

Thiothixene 5 MG Oral Capsule

Mylan Pharmaceuticals Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site